0001231919-20-000058.txt : 20200911 0001231919-20-000058.hdr.sgml : 20200911 20200911113346 ACCESSION NUMBER: 0001231919-20-000058 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 EFFECTIVENESS DATE: 20200911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hyper Labs, Inc. CENTRAL INDEX KEY: 0001648717 IRS NUMBER: 465752283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375299 FILM NUMBER: 201170326 BUSINESS ADDRESS: STREET 1: 54 WEST 21ST STREET CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 415-944-9737 MAIL ADDRESS: STREET 1: 54 WEST 21ST STREET CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001648717 Hyper Labs, Inc. ONE WORLD TRADE CENTER 285 FULTON STREET, SUITE 45A NEW YORK NY NEW YORK 10007 607-351-6015 DELAWARE None None Corporation true Peter Brodsky c/o Hyper Labs, Inc., 1 World Trade Ctr 285 FULTON STREET, SUITE 45A New York NY NEW YORK 10007 Executive Officer Director Ron Shah c/o Hyper Labs, Inc., 1 World Trade Ctr 285 FULTON STREET, SUITE 45A New York NY NEW YORK 10007 Director Matthias Turck c/o Hyper Labs, Inc., 1 World Trade Ctr 285 FULTON STREET, SUITE 45A New York NY NEW YORK 10007 Director Elliot Robinson c/o Hyper Labs, Inc., 1 World Trade Ctr 285 FULTON STREET, SUITE 45A New York NY NEW YORK 10007 Director This director was elected to the board of directors on March 9, 2020. Other Technology Decline to Disclose 06b false 2018-11-30 false true false 0 27249891 27249891 0 The Total Offering Amount and the Total Amount Sold includes $6,849,906.69 through the issuance of stock upon conversion of outstanding convertible securities. false 12 0 0 0 false Hyper Labs, Inc. /s/Peter Brodsky Peter Brodsky President and CEO 2020-09-11